<DOC>
	<DOCNO>NCT00661284</DOCNO>
	<brief_summary>A 52-week follow study investigate duration maintenance efficacy patient RA achieve low disease activity clinical trial MRA stop treatment</brief_summary>
	<brief_title>A Study Duration Maintained Efficacy Rheumatoid Arthritis ( RA ) Patients Off Treatment With MRA ( Development Code Tocilizumab , Anti IL-6 Receptor Monoclonal Antibody . )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patients achieve DAS28 &lt; 3.2 last observation least one time point among two previous assessment time point previous study . Patients receive DMARDs immunosuppressant last observation previous study first observation study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>